Cornerstone Planning Group LLC Vyne Therapeutics Inc. Transaction History

Cornerstone Planning Group LLC

  • $322 Billion
  • Q1 2024

A detailed history of Cornerstone Planning Group LLC transactions in Vyne Therapeutics Inc. stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 2 shares of VYNE stock, worth $3. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Holding current value
$3
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024
BUY
$1.71 - $3.07 $3 - $6
2 New
2 $6,000

Others Institutions Holding VYNE

# of Institutions
3
Shares Held
36.5K
Call Options Held
0
Put Options Held
0
View Full List

About VYNE Therapeutics Inc.

VYNE Quotes by TradingView
  • Ticker VYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,005,600
  • Market Cap $105M
  • Description
  • VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, whi...
More about VYNE
Track This Portfolio

Track Cornerstone Planning Group LLC Portfolio

Follow Cornerstone Planning Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Planning Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Planning Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email